| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 57,595 | 60,303 | 56,854 | | Cost of Revenue | 40,287 | 40,230 | 39,705 | | | Gross Profit | 17,308 | 20,073 | 17,149 | | | Operating Expenses | | Research Development | 846 | 1,045 | 1,228 | | Selling General and Administrative | 21,936 | 21,406 | 25,746 | | Non Recurring |
-
| (75) | 437 | | Others | 1,895 | 1,806 | 1,765 | | | | Total Operating Expenses |
-
| 24,182 | 29,176 | | | | Operating Income or Loss | (7,369) | (4,109) | (12,027) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,218 | 1,173 | 899 | | Earnings Before Interest And Taxes | (6,151) | (2,936) | (11,128) | | Interest Expense | 38 | 11 |
-
| | Income Before Tax | (6,189) | (2,947) | (11,128) | | Income Tax Expense | (1,708) | 20 | 143 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,481) | (2,967) | (11,271) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,481) | (2,967) | (11,271) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,481) | ($2,967) | ($11,271) |
|
1.48% Nasdaq 
Income Statement
